HMGCR and myositis disease: The majority of IMNM cases involve the presence of myositis-specific autoantibodies, specifically anti-signal recognition particle (anti-SRP) or anti-3-hydroxy-3-methylglutaryl-coA reductase (anti-HMGCR).